SASKATOON, Saskatchewan, Sept. 29, 2025 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV:PCRX) is pleased to announce that it has filed a preliminary short form base shelf prospectus with the securities commissions in each of the provinces of Canada, other than Quebec. The base shelf prospectus, when made final and effective, will allow the Corporation to ‎qualify the distribution by way of prospectus in Canada of up to $100 million of common shares, preferred ‎shares, warran ...

Core Insights - Reflect Scientific, Inc. is transitioning from the OTCQB Venture Market to the OTCIQ platform to enhance regulatory compliance and investor communication [1][2] - The move to OTCIQ reflects the company's commitment to transparency, growth, and long-term shareholder value, providing a centralized environment for corporate disclosures and improved reporting consistency [2][3] - CEO Kim Boyce stated that this strategic step aims to strengthen visibility and accessibility while expanding the investor base, positioning the company for its next development phase [3] Company Overview - Reflect Scientific, Inc. is based in Orem, Utah, and specializes in innovative cryogenic technologies for the biotechnology, pharmaceutical, medical, and transportation markets [4] - The company develops advanced cryogenic systems, including ultra-low temperature freezers used in pharmaceutical research, vaccine storage, and other critical scientific applications [3][4]